Rethinking Psychiatric Drugs: a Guide for Informed Consent - Grace E. Jackson - 書籍 - AuthorHouse - 9781420867411 - 2005年7月26日
カバー画像とタイトルが一致しない場合、正しいのはタイトルです

Rethinking Psychiatric Drugs: a Guide for Informed Consent

価格
¥ 6.576
税抜

遠隔倉庫からの取り寄せ

発送予定日 年11月3日 - 年11月19日
クリスマスプレゼントは1月31日まで返品可能です
Grace E. Jackson の新しいリリースのお知らせを受け取る
iMusicのウィッシュリストに追加

まだ評価がありません

-- Are patients aware of the fact that pharmacological therapies stress the brain in ways which may prevent or postpone symptomatic and functional recovery ? ==================================================== Rethinking Psychiatric Drugs: A Guide for Informed Consent is a critical appraisal of the medications which an estimated 20% of Americans consume on a regular (and sometimes involuntary) basis. It is the philosophically, epidemiologically, and scientifically supported revelation of how and why psychiatry's drug therapies have contributed to a standard of care which frequently does more to harm than to cure. Extensively researched and documented, the book addresses: -- the process by which psychiatric drugs reach the market -- the history and philosophy of Evidence Based Medicine -- the common flaws in research methodologies which negate the validity of the psychiatric RCT (Randomized Controlled Trial) -- the problem of allostatic load (how drugs stress the body) -- the history, long term effects, and utility of the drugs used to suppress symptoms of depression, psychosis, inattention and hyperactivity -- the effectiveness of alternatives to medication Rethinking Psychiatric Drugs: A Guide for Informed Consent exposes the current crisis in medical ethics and epistemology, and attempts to restore to psychiatry an authentically informed consent to care.

メディア 書籍     Hardcover Book   (ハードカバー付きの本)
リリース済み 2005年7月26日
ISBN13 9781420867411
出版社 AuthorHouse
ページ数 420
寸法 152 × 229 × 27 mm   ·   766 g
言語 英語